ArticleDrug design, development and therapy2024

Cardiometabolic Modulation by Semaglutide Contributes to Cardioprotection in Rats with Myocardial Infarction.

Haihao Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.